Literature DB >> 6206588

Changes in the kallikrein kinin system during acute pancreatitis in man.

A Lasson, K Ohlsson.   

Abstract

Changes in the kallikrein-kinin system were analysed in 19 attacks of acute pancreatitis in man and correlated to the severity and clinical course of the disease. Prekallikrein, kininogen and kallikrein inhibition were significantly lower in blood in severe attacks than in moderate or mild attacks. These changes were even more pronounced in peritoneal fluid, where kallikrein activity was above normal, while kininogen and kallikrein inhibition were nil in severe attacks. Both high and low molecular weight kininogen were decreased, denoting an activation also by kininogenases other than plasma kallikrein. These changes indicate an activation of the kallikreinkinin system in acute severe pancreatitis in man, especially in the abdominal cavity. Although there is a great deal of evidence for activation of the kinin system in experimental shock states in animals (1-4), there are to date rather few studies showing that such an activation takes place in human acute pancreatitis. This lack of clinical studies is mainly explained by the difficulty in measuring activated components of the system, especially since these components are rapidly inactivated in different ways in vivo (5).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206588     DOI: 10.1016/0049-3848(84)90310-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats.

Authors:  Y Etoh; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Int J Pancreatol       Date:  1992-10

2.  Effects of endoscopic variceal sclerotherapy using GT XIII on blood coagulation tests and the renal kallikrein-kinin system.

Authors:  N Yuki; M Kubo; Y Noro; N Hayashi; H Fusamoto; A Ito; M Masuzawa; T Kamada
Journal:  Gastroenterol Jpn       Date:  1990-10

3.  Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.

Authors:  V Gross; J Schölmerich; H G Leser; R Salm; M Lausen; K Rückauer; U Schöffel; L Lay; A Heinisch; E H Farthmann
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

4.  Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.

Authors:  R Berling; K Ohlsson
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 5.  Prognostic factors in acute pancreatitis.

Authors:  P Malfertheiner; J E Domínguez-Muñoz
Journal:  Int J Pancreatol       Date:  1993-08

6.  Impaired mononuclear phagocyte function in patients with severe acute pancreatitis: evidence from studies of plasma clearance of trypsin and monocyte phagocytosis.

Authors:  M Larvin; D J Alexander; S F Switala; M J McMahon
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

7.  Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.

Authors:  H Weidenbach; M M Lerch; T M Gress; D Pfaff; S Turi; G Adler
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  Effects of C1-esterase inhibitor in three models of acute pancreatitis.

Authors:  C Niederau; R Brinsa; M Niederau; R Lüthen; G Strohmeyer; L D Ferrell
Journal:  Int J Pancreatol       Date:  1995-04

9.  Intra-pancreatic release of bradykinin during the course experimental pancreatitis in rat.

Authors:  P Jönsson; K Ohlsson
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.